CLASS I Drug recall · Reported 15 Jul 2015 · FDA Enforcement Report
10% Dextrose Injection, USP Viaflex recalled by Baxter Healthcare
Baxter Healthcare is recalling 10% Dextrose Injection, USP Viaflex, distributed in Puerto Rico. The recall was initiated on 24 Mar 2015 and the FDA has classified it as Class I.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1210-2015
- FDA event ID
- 70926
- Recalling firm
- Baxter Healthcare, Deerfield, IL
- Brand
- Dextrose
- Manufacturer
- Baxter Healthcare Corporation
- Classification
- Class I
- Status
- Terminated
- Recall initiated
- 24 Mar 2015
- FDA classified
- 6 Jul 2015
- Reported
- 15 Jul 2015
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Particulate Matter
- Drug class
- Injectable & IV Drugs
Timeline
| 24 Mar 2015 | Recall initiated by company | |
| 6 Jul 2015 | Classified by FDA | +104 days |
| 15 Jul 2015 | Published in enforcement report | +9 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Presence of Particulate Matter: Products recalled due to presence of particulate matter (metal)
Product as listed by the FDA
10% Dextrose Injection, USP, 250mL VIAFLEX Plastic bags, Manufactured by Baxter Healthcare Corporation 65 Pitts Station Road Marion, North Carolina 28752-7925 for Baxter Healthcare Corporation 1 Baxter Pkwy Deerfield, IL 60015-4625. NDC 0338-0023-02
Where it was distributed
US, Puerto Rico, and Bermuda
Questions about this recall
Why was it recalled?
Presence of Particulate Matter: Products recalled due to presence of particulate matter (metal)
Which lots are affected?
Lot #: C965558 and C963520, Exp 7/31/2016
Where was it sold?
US, Puerto Rico, and Bermuda
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class I mean?
Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
3 other products · FDA event 70926This product is part of a recall event; the main page for the event is 0.9% Sodium Chloride Injection, USP, in Viaflex recalled.
| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS I | 0.9% Sodium Chloride Injection, USP, in Viaflex recalledSodium Chloride | Baxter Healthcare | Particulate Matter | PR | |
| CLASS I | 5% Dextrose Injection, USP Viaflex recalled by Baxter HealthcareDextrose | Baxter Healthcare | Particulate Matter | PR | |
| CLASS I | Lactated Ringers Injection, USP Viafelx recalled by Baxter HealthcareLactated Ringers | Baxter Healthcare | Particulate Matter | PR |
More recalls from Baxter Healthcare
All 577| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | PRO+ 36" MRS Surface, mattress recalled by Baxter Healthcare | Baxter Healthcare | Packaging Defects | Nationwide |
| Device | CLASS II | Pro+ Mrs Surface For Versacare, mattress recalled by Baxter Healthcare | Baxter Healthcare | Packaging Defects | Nationwide |
| Device | CLASS II | Volara System Volara, HC, NA recalled by Baxter Healthcare | Baxter Healthcare | Device Malfunction | Nationwide |
| Device | CLASS II | PRO+ 40" MRS Surface, mattress recalled by Baxter Healthcare | Baxter Healthcare | Packaging Defects | Nationwide |
| Drug | CLASS I | Dextrose Injection, USP, 70 % recalled by Baxter Healthcare | Baxter Healthcare | Particulate Matter | Nationwide |
Other Dextrose recalls
All 44| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Dextrose Injection, USP, 70 % recalled by Baxter Healthcare | Baxter Healthcare | Particulate Matter | Nationwide |
| Drug | CLASS II | Dextrose Injection recalled by B Braun MedicalDextrose | B Braun Medical | Sterility | Nationwide |
| Drug | CLASS II | 5% Dextrose Injection, USP per (50 mg per mL) in a freeflex recalledDextrose | Fresenius Kabi USA | Sterility | Nationwide |
| Drug | CLASS II | 5% Dextrose Injection, USP per (50 mg per mL) in a freeflex recalledDextrose | Fresenius Kabi USA | Sterility | Nationwide |
| Drug | CLASS II | 5% Dextrose Injection, USP per (50 mg per mL) in a freeflex recalledDextrose | Fresenius Kabi USA | Sterility | Nationwide |